GenAI and its impact on pharma: Insights from Inizio experts

2 March 2026

The latest edition of PME has landed, and it features insights from experts across Inizio. 

Sharing expert insights on GenAI in pharma 

In this special feature on GenAI, PME explores the race to harness GenAI in health and life sciences, and how AI has graduated from being a procurer of efficiencies to an enabler of possibilities.  

This edition also highlights the importance of embracing the GenAI transformation with caution, emphasizing the need to prepare organizations to understand which tools they would benefit from, and how to best use them.  

What is featured in this edition of PME? 

In this feature, Inizio experts explore:  

1. How AI is quietly rewriting your brand narrative 

By Julie O’Donnell, EVP Global Head of Digital at Inizio Evoke Comms 

Clients ask ChatGPT about a disease area, treatment pathway or, increasingly, their own brand. They don’t love its answer and come to us with a request: Can we influence what AI says? 

In this article, Julie explores how CognitevGEO allows clients to align communications, marketing, and expertise around the full context AI uses to form its worldview. 

Read the full article. 

2. How STEM AI helps organizations understand and improve HCP interactions at scale 

By Adam Boucher, Head of Innovation & Product Development at STEM, Inizio Ignite 

Every day, life sciences field teams engage in conversations that shape perception, understanding, and decision-making. These exchanges are where strategy meets reality, but the insight they generate has not always been easy to translate into action. 

In this article, Adam explores how STEM AI enables organizations to move beyond assumptions by drawing insight directly from real interactions. 

Read the full article.  

3. How HCP Interact is advancing Medical Affairs performance with AI-enabled precision 

By Kelly Malloy, Senior Vice President, Customer Engagement – Augmented Intelligence & Artificial Intelligence, Inizio Medical 

Expectations in Medical Affairs have expanded rapidly – deeper scientific exchange, sharper insights, and measurable impact on medical success – while the complexity of the environment continues to intensify. For MSLs, this means every interaction with a HCP carries more strategic weight than ever before. 

In this article, Kelly explores iON AI™ HCP Interact – designed to reimagine how MSLs and field representatives build HCP exchange excellence – not as isolated training, but as a connected enablement capability embedded within the Medical Affairs and commercial space more broadly. 

Read the full article. 

Enabling Intelligent Commercialization™ 

At Inizio, we’re reimagining the future of health through Intelligent Commercialization™. 

Our framework of platforms, products – like CognitevGEO, iON AI™ HCP Interact, and STEM AI – and solutions connect human insight with data, technology, and AI to accelerate smarter, faster decisions and real-world impact across the lifecycle. 

Learn more about Intelligent Commercialization™ here.